-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Sarah Sneeringer
Sarah is Director, Programs at the Biotechnology Industry Organization where she is responsible for developing the program for the BIO International Convention. Sarah spent nine and a half years at the National Association of Chain Drug Stores (NACDS) where she held various roles in programming, grassroots outreach and fundraising. She has served on the board of directors of the NACDS Foundation, National Council for Patient Information and Education (NCPIE) and the Boys and Girls Club of Alexandria.
Sarah graduated from the University of Delaware with a marketing degree and is originally from Shillington, Pennsylvania. In her spare time she enjoys watching the Phillies win, running, traveling, spending time with family and friends and HGTV.Latest Posts
Forbes 30 Under 30: Rising Biotech Stars at the 2013 BIO International Convention
For the second year in a row, Forbes magazine published a list of the most awe-inspiring rising stars in science and healthcare – all under the age of 30. A select group of these rising stars will attend the 2013 BIO International Convention and participate in a Keynote Luncheon Tuesday, April 23, with BIO President and CEO Jim Greenwood. Keynotes and evening events are open to Convention Access and Full Convention Access Registrations! Registration discounts Read More >
Programming Updates to the 2012 BIO International Convention
With Convention less than four months away, things are quickly falling in to place with several programming updates to note! A total of 115 breakout sessions have been confirmed and scheduled, including 18 international case studies. Session organizers are currently finalizing speakers. All session descriptions and confirmed speakers are available on myBIO. Even after all of the session submissions work, we asked for more session ideas! We recently completed a call for “Late-Breaking” sessions in Read More >
2012 BIO International Convention to Highlight Breakthroughs
2012 BIO International Convention to Highlight Breakthroughs in Healing, Fueling, and Feeding the World The BIO International Convention Program Committee recently selected 125 thought-provoking and timely sessions among 13 educational tracks. The 2012 tracks include: Achieving Regulatory Approval and Compliance; Biofuels and Biobased Chemicals; Biotech Patenting and Tech Transfer; Business Development; Drug Discovery and Development; Finance; Food and Agriculture; Global Innovation and Markets; Health Policy and Reimbursement; Innovations in Vaccines; International Case Studies; Manufacturing of Read More >
Behind the Global Stage at BIO
After more than nine and a half years at the National Association of Chain Drug Stores, I joined BIO three months prior to the biggest event of the year, the 2011 BIO International Convention here in Washington, DC. While that may sound like plenty of time to finish planning the Convention’s programming, coordinating 125 breakout sessions and 800+ speakers, 6 super sessions, 2 keynotes, a Leadership Summit, a Translational Research Forum, Diabetes Forum, Emerging Leaders Read More >
